Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantes

Detalhes bibliográficos
Autor(a) principal: Ferreira, Cristiane Janson
Data de Publicação: 2017
Tipo de documento: Trabalho de conclusão de curso
Idioma: por
Título da fonte: Repositório Universitário da Ânima (RUNA)
Texto Completo: https://repositorio.animaeducacao.com.br/handle/ANIMA/9252
Resumo: Introduction: Vasculitis are associated with high morbi-mortality caused by cardiovascular disease, through accelerated atherosclerosis. This process has a multifactorial risk factors, which could be related to aspects of the inflammatory disease itself, to the use of steroids and to the presence of traditional risk factors of cardiovascular diseases. Objective: Analyze if patients with large vessels vasculitis (LVV) have higher frequency of comorbidities and compare the prevalence between Takayasu arteritis (TAA) and giant cell arteritis (GCA). Method: 45 medical records of patients who had LVV were analyzed in a retrospective study in Florianopolis, Brazil. Demographic data were collected, as well as related to clinical tidings. These data were compared between the vasculitis groups (TAA and GCA) through analysis on SPSS 18.0, t-student test and chi-squared test or Fisher’s exact test, p ≤ 0,05. Project was approved by Human Research Ethics Committee of the related institutions. Results: Among the 45 patients, 22 had TAA and 23 had GCA. 84,4% of the patients were women. The percentage of systemic arterial hypertension, diabetes mellitus and dyslipidemia on TAA were 77,3%, 9,1% and 95,5%, respectively. In the same order these comorbidities were found in GCA patients in 87%, 39,1% and 100%. The control of dyslipidemia was not satisfactory in both groups. Lipid profile did not have a significant difference between TAA and GCA. Conclusion: Patients with GCA have higher prevalence of diabetes mellitus when compared to general population and to TAA. The higher prevalence of systemic arterial hypertension and dyslipidemia found in LVV combined with endothelial inflammation due to vasculitis can contribute to accelerate atherosclerosis and should be evaluated and well treated.
id Ânima_6cd2f7d3663baa961c4e8a163d0aa7c9
oai_identifier_str oai:repositorio.animaeducacao.com.br:ANIMA/9252
network_acronym_str Ânima
network_name_str Repositório Universitário da Ânima (RUNA)
repository_id_str
spelling Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantesArterite de TakayasuArterite de células gigantesDislipidemiasDiabetes MellitusHipertensão Arterial SistêmicaComorbidadeIntroduction: Vasculitis are associated with high morbi-mortality caused by cardiovascular disease, through accelerated atherosclerosis. This process has a multifactorial risk factors, which could be related to aspects of the inflammatory disease itself, to the use of steroids and to the presence of traditional risk factors of cardiovascular diseases. Objective: Analyze if patients with large vessels vasculitis (LVV) have higher frequency of comorbidities and compare the prevalence between Takayasu arteritis (TAA) and giant cell arteritis (GCA). Method: 45 medical records of patients who had LVV were analyzed in a retrospective study in Florianopolis, Brazil. Demographic data were collected, as well as related to clinical tidings. These data were compared between the vasculitis groups (TAA and GCA) through analysis on SPSS 18.0, t-student test and chi-squared test or Fisher’s exact test, p ≤ 0,05. Project was approved by Human Research Ethics Committee of the related institutions. Results: Among the 45 patients, 22 had TAA and 23 had GCA. 84,4% of the patients were women. The percentage of systemic arterial hypertension, diabetes mellitus and dyslipidemia on TAA were 77,3%, 9,1% and 95,5%, respectively. In the same order these comorbidities were found in GCA patients in 87%, 39,1% and 100%. The control of dyslipidemia was not satisfactory in both groups. Lipid profile did not have a significant difference between TAA and GCA. Conclusion: Patients with GCA have higher prevalence of diabetes mellitus when compared to general population and to TAA. The higher prevalence of systemic arterial hypertension and dyslipidemia found in LVV combined with endothelial inflammation due to vasculitis can contribute to accelerate atherosclerosis and should be evaluated and well treated.Introdução: As vasculites sistêmicas estão associadas a maior morbidade e mortalidade por doença cardiovascular, mediante aterosclerose acentuada. Esse processo tem origem multifatorial, podendo relacionar-se a aspectos da própria doença inflamatória, ao uso de corticóides e à presença de fatores de risco tradicionais para doença cardiovascular. Objetivo: Analisar se pacientes com vasculites de grandes vasos apresentam maior frequência de comorbidades e comparar a prevalência entre arterite de Takayasu (ATA) e arterite de células gigantes (ACG). Método: Foram analisados 45 prontuários de pacientes com vasculites de grandes vasos na Grande Florianópolis, Brasil, em estudo retrospectivo. Aspectos demográficos, clínicos, medicamentosos foram avaliados e comparados entre os grupos de vasculite (ATA e ACG) por análise no SPSS 18.0, teste t e teste Qui-quadrado ou prova exata de Fisher, p ≤ 0,05. Aprovado pelo Comitê de Ética em Pesquisa das instituições relacionadas. Resultados: Dos 45 pacientes, 22 eram portadores de ATA e 23 de ACG, e 84,4% dos participantes eram mulheres. O percentual de hipertensão arterial sistêmica, diabetes mellitus e dislipidemia na ATA foi 77,3%, 9,1% e 95,5%, respectivamente. Nessa mesma ordem, obteve-se na ACG 87%, 39,1% e 100%. O controle da dislipidemia não foi satisfatório. O perfil lipídico não apresentou variação significativa entre as duas vasculites. Conclusão: Pacientes com ACG tem prevalência elevada de diabetes mellitus quando comparados à população geral e a ATA. A maior prevalência encontrada de hipertensão arterial sistêmica e dislipidemia nos pacientes com vasculites de grandes vasos associada à inflamação endotelial desses pacientes pode contribuir para acelerar a aterogênese, devendo ser avaliada e adequadamente tratada.Pereira, Ivânio AlvesFerreira, Cristiane Janson2017-07-13T00:32:37Z2020-11-29T02:03:47Z2017-07-13T00:32:37Z2020-11-29T02:03:47Z2017info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesis60 f.application/pdfhttps://repositorio.animaeducacao.com.br/handle/ANIMA/9252Medicina - Pedra BrancaPalhoçaAttribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccessporreponame:Repositório Universitário da Ânima (RUNA)instname:Ânima Educaçãoinstacron:Ânima2020-12-02T03:58:48Zoai:repositorio.animaeducacao.com.br:ANIMA/9252Repositório InstitucionalPRIhttps://repositorio.animaeducacao.com.br/oai/requestcontato@animaeducacao.com.bropendoar:2020-12-02T03:58:48Repositório Universitário da Ânima (RUNA) - Ânima Educaçãofalse
dc.title.none.fl_str_mv Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantes
title Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantes
spellingShingle Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantes
Ferreira, Cristiane Janson
Arterite de Takayasu
Arterite de células gigantes
Dislipidemias
Diabetes Mellitus
Hipertensão Arterial Sistêmica
Comorbidade
title_short Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantes
title_full Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantes
title_fullStr Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantes
title_full_unstemmed Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantes
title_sort Comparação da prevalência de comorbidades em pacientes com Arterite de Takayasu e Arterite de células gigantes
author Ferreira, Cristiane Janson
author_facet Ferreira, Cristiane Janson
author_role author
dc.contributor.none.fl_str_mv Pereira, Ivânio Alves
dc.contributor.author.fl_str_mv Ferreira, Cristiane Janson
dc.subject.por.fl_str_mv Arterite de Takayasu
Arterite de células gigantes
Dislipidemias
Diabetes Mellitus
Hipertensão Arterial Sistêmica
Comorbidade
topic Arterite de Takayasu
Arterite de células gigantes
Dislipidemias
Diabetes Mellitus
Hipertensão Arterial Sistêmica
Comorbidade
description Introduction: Vasculitis are associated with high morbi-mortality caused by cardiovascular disease, through accelerated atherosclerosis. This process has a multifactorial risk factors, which could be related to aspects of the inflammatory disease itself, to the use of steroids and to the presence of traditional risk factors of cardiovascular diseases. Objective: Analyze if patients with large vessels vasculitis (LVV) have higher frequency of comorbidities and compare the prevalence between Takayasu arteritis (TAA) and giant cell arteritis (GCA). Method: 45 medical records of patients who had LVV were analyzed in a retrospective study in Florianopolis, Brazil. Demographic data were collected, as well as related to clinical tidings. These data were compared between the vasculitis groups (TAA and GCA) through analysis on SPSS 18.0, t-student test and chi-squared test or Fisher’s exact test, p ≤ 0,05. Project was approved by Human Research Ethics Committee of the related institutions. Results: Among the 45 patients, 22 had TAA and 23 had GCA. 84,4% of the patients were women. The percentage of systemic arterial hypertension, diabetes mellitus and dyslipidemia on TAA were 77,3%, 9,1% and 95,5%, respectively. In the same order these comorbidities were found in GCA patients in 87%, 39,1% and 100%. The control of dyslipidemia was not satisfactory in both groups. Lipid profile did not have a significant difference between TAA and GCA. Conclusion: Patients with GCA have higher prevalence of diabetes mellitus when compared to general population and to TAA. The higher prevalence of systemic arterial hypertension and dyslipidemia found in LVV combined with endothelial inflammation due to vasculitis can contribute to accelerate atherosclerosis and should be evaluated and well treated.
publishDate 2017
dc.date.none.fl_str_mv 2017-07-13T00:32:37Z
2017-07-13T00:32:37Z
2017
2020-11-29T02:03:47Z
2020-11-29T02:03:47Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/bachelorThesis
format bachelorThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.animaeducacao.com.br/handle/ANIMA/9252
url https://repositorio.animaeducacao.com.br/handle/ANIMA/9252
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Medicina - Pedra Branca
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 60 f.
application/pdf
dc.coverage.none.fl_str_mv Palhoça
dc.source.none.fl_str_mv reponame:Repositório Universitário da Ânima (RUNA)
instname:Ânima Educação
instacron:Ânima
instname_str Ânima Educação
instacron_str Ânima
institution Ânima
reponame_str Repositório Universitário da Ânima (RUNA)
collection Repositório Universitário da Ânima (RUNA)
repository.name.fl_str_mv Repositório Universitário da Ânima (RUNA) - Ânima Educação
repository.mail.fl_str_mv contato@animaeducacao.com.br
_version_ 1767415810875195392